NCT02187523View on ClinicalTrials.gov

Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

December 31, 1999

Conditions
Healthy
Interventions
DRUG

Hydrochlorothiazide

DRUG

Telmisartan

DRUG

Telmisartan/HCTZ FDC

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02187523 - Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects | Biotech Hunter | Biotech Hunter